Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000930413-03-000646
Filing Date
2003-02-28
Accepted
2003-02-28 17:19:27
Documents
19
Period of Report
2003-03-14

Document Format Files

Seq Description Document Type Size
1 c26519_pre14a.htm PRE 14A 343224
3 GRAPHIC c_010bweps.jpg GRAPHIC 22916
4 GRAPHIC c_011eps.jpg GRAPHIC 23686
5 GRAPHIC c_012eps.jpg GRAPHIC 23458
6 GRAPHIC c_013bweps.jpg GRAPHIC 22712
7 GRAPHIC c_014eps.jpg GRAPHIC 23058
8 GRAPHIC c_015eps.jpg GRAPHIC 24042
9 GRAPHIC c_016bweps.jpg GRAPHIC 22376
10 GRAPHIC c_019eps.jpg GRAPHIC 23472
11 GRAPHIC c_022eps.jpg GRAPHIC 23570
12 GRAPHIC c_024bweps.jpg GRAPHIC 22278
13 GRAPHIC c_026eps.jpg GRAPHIC 24148
14 GRAPHIC c_028bweps.jpg GRAPHIC 22658
15 GRAPHIC c_038tif.jpg GRAPHIC 15048
16 GRAPHIC c_039tif.jpg GRAPHIC 14898
17 GRAPHIC c_26519charteps.jpg GRAPHIC 225825
18 GRAPHIC c_logo8p.jpg GRAPHIC 32052
19 GRAPHIC c_recycletif.jpg GRAPHIC 2830
20 GRAPHIC c_soyinktif.jpg GRAPHIC 8651
  Complete submission text file 0000930413-03-000646.txt   924408
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

EIN.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-03619 | Film No.: 03587611
SIC: 2834 Pharmaceutical Preparations